Research and Markets: Diabetes Landscape: Market, Technology and Intellectual Property

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/jddm7x/diabetes) has announced the addition of the "Diabetes Landscape: Market, Technology and Intellectual Property" report to their offering.

The International Diabetes Federation (IDF) estimates that the number will reach 552 million by 2030 if no urgent action is taken. This equates to approximately three new cases every 10 seconds or almost 10 million a year. In some of the poorest regions in the world, where infectious diseases have traditionally been the focus of healthcare systems, diabetes cases are expected to increase by 90% by 2030.

While most of the increase in diabetes prevalence is associated with the Type 2 form, the IDF also estimates there is a 3% increase annually in Type 1 diabetes in children aged under 15. Its data show there were 490,100 children in this age group globally with the condition in 2011 and the number of cases is rising by 77,800 annually.

Publication Overview

This volume provides an in-depth analysis of the technologies and IP associated with diabetes devices, including:

Diabetes Monitoring

• Blood glucose meters and test strips
• Continuous glucose monitoring
• Non-invasive and emerging technologies

Diabetes Treatment

• Insulin delivery (including pens and insulin pumps)
• Open loop continuous glucose monitoring/pumps
• Closed loop artificial pancreas technology
• Software & Algorithms

There are a significant number (over 500) of patent assignees. This report provides detailed analysis of:

• Overall diabetes patent portfolio (including Priority Year, Patent Totals by Technology, Top Twenty Assignees, IPC and USP Classifications)
• Diabetes patents by technology subcategory (including Priority Date, Top Twenty Assignees, and Analysis of Sample Patents)
• Diabetes patents by key company (including Priority Date, Patent Distribution by Technology, and Patent Source Jurisdiction)

Analysis and commentary include discussion of the patent and product portfolio coverage of key companies. There are significant research and product development areas where leading companies lack coverage.

Investigation of assignee by technology group and forward citations of key patents provides insight into the large number of players and identifies potential targets for acquisition.

Use this report to...

• Appreciate the value of monitoring and treatment markets
• Know the market share of leading companies
  
• Assess new technologies and treatments which will change the market
• Access detailed patent and technology analysis for the detection, treatment and monitoring of diabetes
• Understand the emerging trends and commercialisation status
• Compare and contrast the technology portfolio in major companies through their patent activities
• Drill down into intellectual property trends in the diabetes device sector and see how they relate to market opportunities

Companies Mentioned

• Abbott
• Arkray
• Bayer
• Becton Dickinson
• DexCom
• Insulet
• J&J
• Medtronic
• Nipro
• Novo Nordisk
• Roche
• Sanofi-aventis

For more information visit http://www.researchandmarkets.com/research/jddm7x/diabetes

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.